相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Exploiting the curative potential of adoptive T-cell therapy for cancer
Christian S. Hinrichs et al.
IMMUNOLOGICAL REVIEWS (2014)
Cytosolic-DNA-Mediated, STING-Dependent Proinflammatory Gene Induction Necessitates Canonical NF-κB Activation through TBK1
Takayuki Abe et al.
JOURNAL OF VIROLOGY (2014)
Type I interferons induce autophagy in certain human cancer cell lines
Hana Schmeisser et al.
AUTOPHAGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses
Hyun-Il Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Type I interferon response and innate immune sensing of cancer
Mercedes B. Fuertes et al.
TRENDS IN IMMUNOLOGY (2013)
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
Juergen C. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers
Kelly Barrios et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
A Potent Vaccination Strategy That Circumvents Lymphodepletion for Effective Antitumor Adoptive T-cell Therapy
Hyun-Il Cho et al.
CANCER RESEARCH (2012)
The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response
Kislay Parvatiyar et al.
NATURE IMMUNOLOGY (2012)
Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system
Chang Shu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Interferon γ limits the effectiveness of melanoma peptide vaccines
Hyun-Il Cho et al.
BLOOD (2011)
MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP
Lei Jin et al.
JOURNAL OF IMMUNOLOGY (2011)
STING is a direct innate immune sensor of cyclic di-GMP
Dara L. Burdette et al.
NATURE (2011)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine
Adam Dangoor et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation
Ian Horkheimer et al.
BLOOD (2009)
Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects
Hyun-Il Cho et al.
CANCER RESEARCH (2009)
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
Sarah M. McWhirter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The MHC class I peptide repertoire is molded by the transcriptome
Marie-Helene Fortier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Bacterial c-di-GMP is an immunostimulatory molecule
David K. R. Karaolis et al.
JOURNAL OF IMMUNOLOGY (2007)
Signals required for programming effector and memory development by CD8(+) T cells
Matthew F. Mescher et al.
IMMUNOLOGICAL REVIEWS (2006)
Cutting edge: Type IIFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation
JM Curtsinger et al.
JOURNAL OF IMMUNOLOGY (2005)
New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population
I Jedema et al.
BLOOD (2004)
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
WW Overwijk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses
JW Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides
S Zwaveling et al.
JOURNAL OF IMMUNOLOGY (2002)
Challenges in the development of effective peptide vaccines for cancer
C Buteau et al.
MAYO CLINIC PROCEEDINGS (2002)
Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates
LZ Liu et al.
NATURE MEDICINE (2002)
分享论文
